PURPOSE: Male pattern baldness (MPB) and prostate cancer (PCa) share commonality as prevalent, heritable and androgen-related conditions. Studies exploring the relationship between the two conditions have been inconclusive. Using a population-based, case-control study of PCa, we explore the relationship between early-onset MPB and PCa risk. METHODS: Cases were men aged 35-74 diagnosed with PCa between 2002 and 2005 in King County, Washington. Controls were frequency matched by age and identified by random digit dialing. Hair pattern at age 30 and at 1 year prior to diagnosis (cases) or reference date (controls) was determined using showcards. PCa risk associated with balding was assessed with logistic regression. RESULTS: Data from 999 cases of PCa and 942 controls were analyzed. Hair loss at age 30 was more common in controls (25.2%) than cases (19.8%, p=0.005), and those with hair loss at age 30 had a 29% relative risk reduction for PCa (OR 0.71, 95% CI 0.56-0.91). No risk reduction was seen for men only reporting hair loss at referent age (OR 0.90, 95% CI 0.73-1.12). In men aged >60 at referent date, the risk reduction was greater for men with hair loss at age 30 from both the top of head and forehead (OR 0.55, 95% CI 0.33-0.93). CONCLUSION: Early-onset MPB was associated with a reduced relative risk of PCa in this population-based study. Further research into a possible mechanistic link between these prevalent and androgen-related conditions is warranted.
PURPOSE:Male pattern baldness (MPB) and prostate cancer (PCa) share commonality as prevalent, heritable and androgen-related conditions. Studies exploring the relationship between the two conditions have been inconclusive. Using a population-based, case-control study of PCa, we explore the relationship between early-onset MPB and PCa risk. METHODS: Cases were men aged 35-74 diagnosed with PCa between 2002 and 2005 in King County, Washington. Controls were frequency matched by age and identified by random digit dialing. Hair pattern at age 30 and at 1 year prior to diagnosis (cases) or reference date (controls) was determined using showcards. PCa risk associated with balding was assessed with logistic regression. RESULTS: Data from 999 cases of PCa and 942 controls were analyzed. Hair loss at age 30 was more common in controls (25.2%) than cases (19.8%, p=0.005), and those with hair loss at age 30 had a 29% relative risk reduction for PCa (OR 0.71, 95% CI 0.56-0.91). No risk reduction was seen for men only reporting hair loss at referent age (OR 0.90, 95% CI 0.73-1.12). In men aged >60 at referent date, the risk reduction was greater for men with hair loss at age 30 from both the top of head and forehead (OR 0.55, 95% CI 0.33-0.93). CONCLUSION: Early-onset MPB was associated with a reduced relative risk of PCa in this population-based study. Further research into a possible mechanistic link between these prevalent and androgen-related conditions is warranted.
Authors: W Demark-Wahnefried; S M Lesko; M R Conaway; C N Robertson; R V Clark; B Lobaugh; B J Mathias; T S Strigo; D F Paulson Journal: J Androl Date: 1997 Sep-Oct
Authors: Ghazi Al Edwan; Bimal Bhindi; David Margel; Karen Chadwick; Antonio Finelli; Alexandre Zlotta; John Trachtenberg; Neil Fleshner Journal: Can Urol Assoc J Date: 2016-12-12 Impact factor: 1.862
Authors: Saud Khan; Joshua Caldwell; Travis A Gerke; Sarah C Markt; Kathryn M Wilson; Amparo G Gonzalez-Feliciano; Samuel Peisch; Claire H Pernar; Rebecca E Graff; Edward L Giovannucci; Lorelei A Mucci Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-04-10 Impact factor: 4.254
Authors: Cindy Ke Zhou; Alyson J Littman; Paul H Levine; Heather J Hoffman; Sean D Cleary; Emily White; Michael B Cook Journal: Prostate Date: 2014-12-09 Impact factor: 4.104
Authors: Jean-Alfred Thomas; Jodi A Antonelli; Lionel L Banez; Catherine Hoyo; Delores Grant; Wendy Demark-Wahnefried; Elizabeth A Platz; Leah Gerber; Kathryn Shuler; Enwono Eyoh; Elizabeth Calloway; Stephen J Freedland Journal: Cancer Causes Control Date: 2013-03-26 Impact factor: 2.506
Authors: Cindy Ke Zhou; Paul H Levine; Sean D Cleary; Heather J Hoffman; Barry I Graubard; Michael B Cook Journal: Am J Epidemiol Date: 2016-01-12 Impact factor: 4.897
Authors: Cindy Ke Zhou; Ruth M Pfeiffer; Sean D Cleary; Heather J Hoffman; Paul H Levine; Lisa W Chu; Ann W Hsing; Michael B Cook Journal: J Clin Oncol Date: 2014-09-15 Impact factor: 44.544
Authors: Rui Li; Felix F Brockschmidt; Amy K Kiefer; Hreinn Stefansson; Dale R Nyholt; Kijoung Song; Sita H Vermeulen; Stavroula Kanoni; Daniel Glass; Sarah E Medland; Maria Dimitriou; Dawn Waterworth; Joyce Y Tung; Frank Geller; Stefanie Heilmann; Axel M Hillmer; Veronique Bataille; Sibylle Eigelshoven; Sandra Hanneken; Susanne Moebus; Christine Herold; Martin den Heijer; Grant W Montgomery; Panos Deloukas; Nicholas Eriksson; Andrew C Heath; Tim Becker; Patrick Sulem; Massimo Mangino; Peter Vollenweider; Tim D Spector; George Dedoussis; Nicholas G Martin; Lambertus A Kiemeney; Vincent Mooser; Kari Stefansson; David A Hinds; Markus M Nöthen; J Brent Richards Journal: PLoS Genet Date: 2012-05-31 Impact factor: 5.917
Authors: Elizabeth A Tindall; M S Riana Bornman; Smit van Zyl; Alpheus M Segone; L Richard Monare; Philip A Venter; Vanessa M Hayes Journal: BMC Urol Date: 2013-12-29 Impact factor: 2.264